v3.26.1
Consolidated Statements of Changes in Shareholders’ Equity (Deficits) - USD ($)
Ordinary shares
Previosly Reported
Ordinary shares
Recapitalization
Ordinary shares
Additional paid-in capital
Previosly Reported
Additional paid-in capital
Recapitalization
Additional paid-in capital
Accumulated deficit
Previosly Reported
Accumulated deficit
Recapitalization
Accumulated deficit
Accumulative other comprehensive income
Previosly Reported
Accumulative other comprehensive income
Recapitalization
Accumulative other comprehensive income
Previosly Reported
Recapitalization
Total
Balance at Dec. 31, 2022 $ 105,200 $ (98,727) $ 6,473 $ 386,067 $ 98,727 $ 484,794 $ (529,044) $ (529,044) $ 47,112 $ 47,112 $ 9,335 $ 9,335
Balance (in Shares) at Dec. 31, 2022 1,051,997 63,678,414 64,730,411                        
Net income loss             13,560         13,560
Foreign currency translation adjustment                 99     99
Balance at Dec. 31, 2023     $ 6,473     484,794     (515,484)     47,211     22,994
Balance (in Shares) at Dec. 31, 2023     64,730,411                        
Issuance of common shares (as adjusted for the Reverse Recapitalization)         7,980,950             7,980,950
Net income loss             (1,411,559)         (1,411,559)
Foreign currency translation adjustment                 (2,139)     (2,139)
Balance at Dec. 31, 2024     $ 6,473     8,465,744     (1,927,043)     45,072     $ 6,590,246
Balance (in Shares) at Dec. 31, 2024     64,730,411                       64,730,411 [1]
Issuance of Common shares per Business Combination     $ 579     13,199,421             $ 13,200,000
Issuance of Common shares per Business Combination (in Shares)     5,790,937                        
Issuance of Common Shares per Warrants exercise     $ 27     2,642,399             2,642,426
Issuance of Common Shares per Warrants exercise (in Shares)     267,913                        
Reverse Recapitalization transaction         448,476             448,476
Recognition of warrant liabilities assumed in the Business Combination         (13,746,147)             (13,746,147)
Adjustment to deferred offering costs         (3,848,212)             (3,848,212)
Net income loss             (8,311,316)         (8,311,316)
Foreign currency translation adjustment                 168,864     168,864
Balance at Dec. 31, 2025     $ 7,079     $ 7,161,681     $ (10,238,359)     $ 213,936     $ (2,855,663)
Balance (in Shares) at Dec. 31, 2025     70,789,261                       70,789,261 [1]
[1] Shares related information and additional paid-in capital are retrospectively restated for effect of recapitalization completed on August 28, 2025.